We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pharma Equity Group A/s | LSE:0REU | London | Ordinary Share | DK0061155009 | PHARMA EQUITY GROUP ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 3.48M | 0.2392 | 1.67 | 5.82M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 0.40 | DKK |
Date | Time | Source | Headline |
---|---|---|---|
16/4/2024 | 16:29 | UKREG | Passing of the General Meeting of Pharma Equity Group A/S |
10/4/2024 | 13:21 | UKREG | The Board of Director's decision to issue convertible loans |
05/4/2024 | 10:22 | UKREG | Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports.. |
25/3/2024 | 12:06 | UKREG | Notice convening the annual general meeting in Pharma Equity Group A/S |
22/3/2024 | 08:00 | UKREG | Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on.. |
21/3/2024 | 15:32 | UKREG | Completion of subscription of convertible loans |
20/3/2024 | 07:58 | UKREG | Pharma Equity Group A/S - Annual Report 2023 |
05/3/2024 | 09:11 | UKREG | Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received.. |
07/2/2024 | 12:38 | UKREG | Completion of subscription of convertible loans |
07/2/2024 | 08:46 | UKREG | The Board of Director's decision to issue convertible loans |
Pharma Equity Group A/s (0REU) Share Charts1 Year Pharma Equity Group A/s Chart |
|
1 Month Pharma Equity Group A/s Chart |
Intraday Pharma Equity Group A/s Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions